Eui Ho Park

Dr. Eui Ho Park

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2023 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
EPEui Ho Park
Eui Ho Park
JSJinwon Seo
Jinwon Seo
YLYunsin Lee
Yunsin Lee
KPKiwon Park
Kiwon Park
KKKyung-Ran Kim
Kyung-Ran Kim
HCHeonsik Choi
Heonsik Choi
TissueGene-C (TG-C), a combination of human allogeneic chondrocytes and irradiated GP2-293 cells engineered to overexpress transforming growth factor-β1 (TGF-β1), has been developed as a novel cell-based gene therapy and a candidate for disease modifying osteoarthritis drug (DMOAD). We aim to investigate analgesic mechanism of TG-C in a pre-clinical animal model with monoiodoacetate (MIA)-induced pain. We used a rat MIA model of osteoarthritis (OA) pain. We examined that TG-C can regulate pain by inhibiting the upregulation of various pain mediators in both knee joint tissue and dorsal root ganglia (DRG) (n = 112) and alleviating pain behavior (n = 41) and neuronal hyperexcitability in DRG (n = 60), afferent nerve fiber (n = 24), and spinal cord (n = 35). TG-C significantly alleviated pain-related behavior by restoring altered dynamic weight bearing and reduced mechanical threshold of the affected hindlimb. TG-C significantly suppressed the expression of nerve growth factor (NGF) and calcitonin gene-related peptide (CGRP) in inflamed joint tissue. TG-C significantly suppressed the upregulation of tropomyosin receptor kinase A (TrkA) and nerve injury/regeneration protein (GAP43) and activation of Iba1-positive microglial cells in DRG. TG-C significantly recovered neuronal hyperexcitability by restoring RMP and firing threshold and frequency of DRG neurons, attenuating firing rates of mechanosensitive C- or Aδ-nerve fiber innervating knee joint, and lowering increased miniature and evoked excitatory postsynaptic currents (mEPSCs and eEPSCs) in the spinal cord. Our results demonstrated that TG-C exerted potent analgesic effects in a rat MIA model of OA pain by inhibiting the upregulation of pain mediators and modulating neuronal sensitization.

4 July 2025 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
MKMinji Kwon
Minji Kwon
TKTaemin Kim
Taemin Kim
EPEui Ho Park
Eui Ho Park
SSSunmi Song
Sunmi Song
HOHogwang Ok
Hogwang Ok
JKJunesun Kim
Junesun Kim
Chronic pain is a major symptom of osteoarthritis (OA). Substance P (SP) plays a role in inflammation and nociception, but its role in OA pain chronicity remains unclear. This study investigates whether SP-neurokinin 1 (NK1R) signal mediates the development of chronic pain in monosodium iodoacetate (MIA)-induced OA model rats. GR 82334 (GR), an NK1R antagonist, was injected intra-articularly 30 minutes before (pre-GR) or 1 day after (post-GR) MIA injection to examine the effects of NK1R blocking of early inflammation on chronic pain and neuroimmune interactions in the knee joint, dorsal root ganglion (DRG), and spinal dorsal horn (SDH). GR reduced edema and knee bending scores; post-GR treatment more effectively prevented paw withdrawal threshold reduction than pre-GR treatment. Early NK1R blocking suppressed the expression of CGRP, SP, and pro-inflammatory factors (CCL2, TNFα, IL-1β, and IL-6), and M1 macrophage activation in the knee joints at 14 days post-MIA. GR also reduced the expression of pro-inflammatory factors and M1 macrophage activation in the L3-5 DRGs and decreased the expression of CGRP, SP, and pro-inflammatory factors, and microglial activation in the L3-5 SDHs. These findings suggest that early SP-NK1R signal-mediated inflammation contributes to OA chronic pain progression via neuroimmune interactions.

1 May 2022 in Life
Verified
Journal Article
Open access
PDF file
EPEui Ho Park
Eui Ho Park
NKNam-Soo Kim
Nam-Soo Kim
YLYeon-Kyung Lee
Yeon-Kyung Lee
JCJune-Seek Choi
June-Seek Choi
Accumulating evidence suggests that the medial prefrontal cortex (mPFC) has been implicated in the acquisition of fear memory during trace fear conditioning in which a conditional stimulus (CS) is paired with an aversive unconditional stimulus (UCS) separated by a temporal gap (trace interval, TI). However, little is known about the role of the prefrontal cortex for short- and long-term trace fear memory formation. Thus, we investigated how the prelimbic (PL) subregion within mPFC in rats contributes to short- and long-term trace fear memory formation using electrolytic lesions and d,l,-2-amino-5-phosphonovaleric acid (APV), an N-methyl-D-aspartate receptor (NMDAR) antagonist infusions into PL. In experiment 1, pre-conditioning lesions of PL impaired freezing to the CS as well as TI during the acquisition and retrieval sessions, indicating that PL is critically involved in trace fear memory formation. In experiment 2, temporary blockade of NMDA receptors in PL impaired the acquisition, but not the expression of short- and long-term trace fear memory. In addition, the inactivation of NMDAR in PL had little effect on locomotor activity, pre-pulse inhibition (PPI), or shock sensitivity. Taken together, these results suggest that NMDA receptor-mediated neurotransmission in PL is required for the acquisition of trace fear memory.


22 January 2026 in Journal of Cellular Physiology
Verified
Journal Article
Open access
YCYun‐Ho Cho
Yun‐Ho Cho
CCCham Choi
Cham Choi
MKMinji Kwon
Minji Kwon
JKJinju Kwon
Jinju Kwon
HOHogwang Ok
Hogwang Ok
EPEui Ho Park
Eui Ho Park
This study aimed to determine whether degeneration of intervertebral discs and subchondral bone correlates with the development of persistent low back pain (LBP) in a rat model with intradiscal monosodium iodoacetate (MIA), focusing on structural alterations, neuronal sensitization, and pain‐related behavior. Male Sprague Dawley rats received MIA injections (2 mg in 2 μl) into L4/5 and L5/6 lumbar discs to induce degeneration. LBP‐related behaviors were assessed over 42 days via dynamic weight‐bearing and hindpaw withdrawal thresholds. Neuronal sensitization was evaluated via electrophysiological recordings of mechanosensitive afferent nerves (MSAN) and calcium imaging of labeled dorsal root ganglia (DRG) neurons innervating discs. Structural alterations in subchondral bone and disc were analyzed using in vivo/ex vivo µCT imaging, along with immunohistochemistry for TRPV1 and CGRP expression. Intradiscal MIA induced long‐term LBP behaviors, characterized by forelimb weight‐bearing shifts and reduced hindpaw withdrawal thresholds. MSAN exhibited hyperexcitability and lowered firing thresholds to intradiscal pressure, while DRG neurons showed enhanced TRPV1‐ and TRPA1‐mediated calcium influx. µCT imaging revealed decreased disc volume and deteriorated trabecular bone quality. Histology confirmed disc and subchondral bone degeneration, with upregulated TRPV1 and CGRP expression in subchondral bone, indicating nociceptive fiber ingrowth. Linear discriminant analysis identified weight‐bearing asymmetry (HindFore AUC), trabecular thickness, connectivity, and trabecular pattern factor as strong predictors of LBP development. Pathological degeneration of disc and bone is associated with chronic LBP through structural remodeling and peripheral neuronal sensitization. These findings suggest that therapeutic strategies targeting both tissues can alleviate chronic pain in degenerative spine conditions.

7 November 2012 in Procedia Engineering
Verified
Journal Article
Open access
PDF file
DKD.Y. Kim
D.Y. Kim
BGBoram Gu
Boram Gu
EPEui Ho Park
Eui Ho Park
Dae Ryook YangDae Ryook Yang
Dae Ryook Yang
This article has been removed: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been removed at the request of the Executive Publisher. This article has been removed because it was published without the permission of the author(s).